Factors associated with lost to follow-up after hepatitis C treatment delivered by primary care teams in an inner-city multi-site program, Vancouver, Canada-Reference-Cited by-同舟云学术

Factors associated with lost to follow-up after hepatitis C treatment delivered by primary care teams in an inner-city multi-site program, Vancouver, Canada

Published:2018-09 Issue: Volume:59 Page:76-84
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Nouch Susan,Gallagher Lesley,Erickson Margaret,Elbaharia Rabab,Zhang Wendy,Wang Lu,Bacani Nic,Kason Deborah,Kleban Holly,Knebel Laura,Hall David,Barrios Rolando,Hull Mark

Funder

Vancouver Coastal Health Research Institute Team Grant Award

VGH & UBC Hospital Foundation

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference37 articles.

1. HCV guidance: Recommendations for testing, managing, and treating hepatitis C;AASLD-IDSA,2018

2. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents;Alavi;Liver International,2014

3. Clinicians’ views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs;Asher;Substance Use & Misuse,2016

4. Delivery of treatment for hepatitis C virus infection in the primary care setting;Baker;European Journal of Gastroenterology & Hepatology [Internet],2014

5. Restrictions for medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States;Barua;Annals of Internal Medicine (American College of Physicians),2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a safety‐net hospital;Journal of Viral Hepatitis;2024-02-18

2. Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care;Journal of Gastroenterology and Hepatology;2023-12-19

3. Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients;Infectious Diseases and Therapy;2023-06-17

4. Improving hepatitis C screening and access to treatment;JAAPA;2022-09-06

5. Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review;BMJ Open;2021-09